Vontobel Holding Ltd. Sells 33,101 Shares of Cardinal Health, Inc. $CAH

Vontobel Holding Ltd. lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 83.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,370 shares of the company’s stock after selling 33,101 shares during the period. Vontobel Holding Ltd.’s holdings in Cardinal Health were worth $1,000,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in Cardinal Health by 3.3% in the 2nd quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after purchasing an additional 205,539 shares in the last quarter. Norges Bank purchased a new stake in shares of Cardinal Health during the second quarter valued at approximately $584,420,000. Invesco Ltd. increased its position in shares of Cardinal Health by 7.3% during the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after purchasing an additional 207,750 shares during the last quarter. Legal & General Group Plc increased its position in shares of Cardinal Health by 2.0% during the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock valued at $394,761,000 after purchasing an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP raised its stake in shares of Cardinal Health by 19.1% during the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock worth $324,402,000 after purchasing an additional 309,335 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.3%

NYSE CAH opened at $208.19 on Friday. The firm has a market cap of $49.46 billion, a P/E ratio of 31.40, a price-to-earnings-growth ratio of 1.52 and a beta of 0.63. The company’s 50 day moving average is $196.29 and its 200-day moving average is $170.14. Cardinal Health, Inc. has a 12-month low of $117.53 and a 12-month high of $214.93.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same period in the previous year, the business earned $1.88 EPS. Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s payout ratio is presently 30.77%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CAH shares. Barclays started coverage on shares of Cardinal Health in a research report on Monday, December 8th. They set an “overweight” rating and a $243.00 price target for the company. Mizuho boosted their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research note on Monday, November 3rd. Robert W. Baird set a $232.00 price target on shares of Cardinal Health in a research note on Friday, October 31st. Wells Fargo & Company lifted their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Finally, Evercore ISI upped their price objective on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $209.00.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.